首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug development research

缩写:DRUG DEVELOP RES

ISSN:0272-4391

e-ISSN:1098-2299

IF/分区:4.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1366
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ahmed S Kamel,Heba Nasr Shalaby,Yasmin A M El-Said et al. Ahmed S Kamel et al.
The loss of intracellular K+ facilitated by different channels such as Panx1, TWIK2, or Kv1.3, is a danger signal that activates programmed cell death in oligodendrocytes via NLRP3 inflammasome and pyroptosis in multiple sclerosis (MS). ATP...
Zhiyong Liu,Hong Hu,Zhiqin Lin et al. Zhiyong Liu et al.
Breast cancer (BC), characterized by a high incidence specifically in women, exhibits a complex etiology. This study aims to investigate the role and underlying mechanism of microrchidia CW-type zinc finger 2 (MORC2) in BC progression. MCF-...
Allysson L Dos S Ferreira,Bruna B Dantas,Jailton De Souza-Ferrari et al. Allysson L Dos S Ferreira et al.
The discovery of Cisplatin marked the beginning of the metallodrug era in oncology. Despite their clinical success, platinum-based compounds present important limitations, including drug resistance and systemic toxicity. These challenges ha...
Shruti Gupta,Nazim Nasir,Shadma Wahab et al. Shruti Gupta et al.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, characterized by late-stage diagnosis, dense desmoplastic stroma, rapid metastatic progression, and poor responsiveness to conventional chemotherapy. Conseq...
Chuanchao Wei,Qing Zhang,Anwei Mao et al. Chuanchao Wei et al.
Astragaloside IV (AS-IV), a natural compound from traditional Chinese medicine, has demonstrated anti-tumor properties. This study aims to explore its potential to enhance anti-mPD-L1 immunotherapy in triple-negative breast cancer (TNBC) by...
Ahammed Ameen Thottasseri,Vinoth Rajendran,Deepthi Ramesh et al. Ahammed Ameen Thottasseri et al.
The emergence of resistance to existing antimalarials, including artemisinin and its combinations, has intensified the need for new chemotypes with improved efficacy. In this study, a scaffold-hopping strategy was employed to design and dev...
Ye Wang,Can Liu,Mingfang Wang et al. Ye Wang et al.
Neuropathic pain (NP), a chronic condition resulting from nerve injury or dysfunction, represents considerable therapeutic difficulties owing to its intricate and multifactorial pathophysiology. Recent studies indicate that dysregulated fat...
Mohamed S Nafie,Mohamed Khaled Diab,Sherif Ashraf Fahmy Mohamed S Nafie
Glioblastoma (GBM) remains one of the most lethal brain malignancies because of its highly immunosuppressive tumor microenvironment and the limited penetration of therapeutics across the blood-brain barrier (BBB). Although recent studies ha...
Wenbo Che,Xinlin Wang,Sijin Chen et al. Wenbo Che et al.
Proteolysis Targeting Chimera (PROTAC) is a bifunctional small molecule composed of a ligand for the target protein, a ligand for an E3 ubiquitin ligase, and a chemical linker. It induces the formation of a ternary complex between the targe...
Naglaa M Ahmed,Mohamed S Gaballah,Belen Altava et al. Naglaa M Ahmed et al.
Following the common structural features of VEGFR-2, EGFR, and HER-2 kinase inhibitors, two newly synthesized series of 3,4-dihydropyrimidine 2(1H)-(thio)ones-5-carboxamide (2a-l) and thiouracil-5-sulfonyl derivatives (4a-e) were evaluated ...